Skip to content

Clinical trials

Completed Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Status: Completed Country / region: France Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20122
20131
20142
20152
20163
20182
20193
20201
20213
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CSL Behring3
Baxalta now part of Shire2
Centre Hospitalier Universitaire de Nice2
Assistance Publique Hopitaux De Marseille1
Bioverativ, a Sanofi company1
Centre Hospitalier Universitaire de Nīmes1
Centre Hospitalier Universitaire de Saint Etienne1
Fondation Hôpital Saint-Joseph1
Fondation Ophtalmologique Adolphe de Rothschild1
Laboratoire français de Fractionnement et de Biotechnologies1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating22
Charcot-Marie-Tooth Disease4
Peripheral Nervous System Diseases3
Polyradiculoneuropathy2
Autoimmune Diseases1
Autoimmune Diseases of the Nervous System1
Demyelinating Diseases1
Immune System Diseases1
Nervous System Diseases1
Neuromuscular Diseases1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.